BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9448143)

  • 1. In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model.
    Bumgardner GL; Li J; Heininger M; Ferguson RM; Orosz CG
    Transplantation; 1998 Jan; 65(1):47-52. PubMed ID: 9448143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functional model of hepatocyte transplantation for in vivo immunologic studies.
    Bumgardner GL; Heininger M; Li J; Xia D; Parker-Thornburg J; Ferguson RM; Orosz CG
    Transplantation; 1998 Jan; 65(1):53-61. PubMed ID: 9448144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of immune responses evoked by allogeneic hepatocytes: evidence for independent co-dominant roles for CD4+ and CD8+ T-cell responses in acute rejection.
    Bumgardner GL; Li J; Prologo JD; Heininger M; Orosz CG
    Transplantation; 1999 Aug; 68(4):555-62. PubMed ID: 10480416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells.
    Bumgardner GL; Orosz CG
    Immunol Rev; 2000 Apr; 174():260-79. PubMed ID: 10807522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
    Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
    Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ T-cell-dependent immune damage of liver parenchymal cells is mediated by alloantibody.
    Horne PH; Lunsford KE; Eiring AM; Wang Y; Gao D; Bumgardner GL
    Transplantation; 2005 Aug; 80(4):514-21. PubMed ID: 16123727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC-identical heart and hepatocyte allografts evoke opposite immune responses within the same host.
    Bumgardner GL; Gao D; Li J; Bickerstaff A; Orosz CG
    Transplantation; 2002 Sep; 74(6):855-64. PubMed ID: 12364867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique CD8+ T Cell-Mediated Immune Responses Primed in the Liver.
    Zimmerer JM; Horne PH; Fisher MG; Pham TA; Lunsford KE; Ringwald BA; Avila CL; Bumgardner GL
    Transplantation; 2016 Sep; 100(9):1907-15. PubMed ID: 27379551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4, KO, and CD8 KO mice.
    Bumgardner GL; Gao D; Li J; Baskin JH; Heininger M; Orosz CG
    Transplantation; 2000 Dec; 70(12):1771-80. PubMed ID: 11152110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of effector macrophages in mediating CD4-dependent alloimmune injury of transplanted liver parenchymal cells.
    Horne PH; Zimmerer JM; Fisher MG; Lunsford KE; Nadasdy G; Nadasdy T; van Rooijen N; Bumgardner GL
    J Immunol; 2008 Jul; 181(2):1224-31. PubMed ID: 18606676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential induction of Th1 responses by functionally mature hepatic (CD8alpha- and CD8alpha+) dendritic cells: association with conversion from liver transplant tolerance to acute rejection.
    Morelli AE; O'Connell PJ; Khanna A; Logar AJ; Lu L; Thomson AW
    Transplantation; 2000 Jun; 69(12):2647-57. PubMed ID: 10910289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tumor necrosis factor alpha and intercellular adhesion molecule-1 expression on immunogenicity of murine liver cells in mice.
    Bumgardner GL; Li J; Apte S; Heininger M; Frankel WL
    Hepatology; 1998 Aug; 28(2):466-74. PubMed ID: 9696013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic parenchymal replacement in mice by transplanted allogeneic hepatocytes is facilitated by bone marrow transplantation and mediated by CD4 cells.
    Streetz KL; Doyonnas R; Grimm D; Jenkins DD; Fuess S; Perryman S; Lin J; Trautwein C; Shizuru J; Blau H; Sylvester KG; Kay MA
    Hepatology; 2008 Feb; 47(2):706-18. PubMed ID: 18220289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of anti-intercellular adhesion molecule-1 immunotherapy on immune responses to allogeneic hepatocytes in mice.
    Bumgardner GL; Li J; Heininger M; Orosz CG
    Hepatology; 1998 Oct; 28(4):1005-12. PubMed ID: 9755237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.
    Avila CL; Zimmerer JM; Elzein SM; Pham TA; Abdel-Rasoul M; Bumgardner GL
    Transplantation; 2016 Sep; 100(9):1898-906. PubMed ID: 27362313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hepatocyte transplantation: contribution of Fas-Fas ligand interaction to allogeneic hepatocyte rejection.
    Kawahara T; Yagita H; Kasai S; Sawa M; Kato K; Okumura K; Futagawa S; Mito M
    J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S119-23. PubMed ID: 9792045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical Role of Macrophage FcγR Signaling and Reactive Oxygen Species in Alloantibody-Mediated Hepatocyte Rejection.
    Zimmerer JM; Liu XL; Blaszczak A; Avila CL; Pham TA; Warren RT; Bumgardner GL
    J Immunol; 2018 Dec; 201(12):3731-3740. PubMed ID: 30397035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells.
    Sugiura K; Kato K; Hashimoto F; Jin T; Amoh Y; Yamamoto Y; Morita H; Okumura K; Ikehara S
    Immunobiology; 1997 Nov; 197(5):460-77. PubMed ID: 9413746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the induction of tolerance to alloantigens. II. The generation of serum factor(s) able to transfer alloantigen-specific tolerance for delayed-type hypersensitivity by portal venous inoculation with allogeneic cells.
    Fujiwara H; Qian JH; Satoh S; Kokudo S; Ikegami R; Hamaoka T
    J Immunol; 1986 Apr; 136(8):2763-8. PubMed ID: 2420865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.